TNYA · Tenaya Therapeutics, Inc. · Investor Relations

$0.42 +0.05 (+12.02%)

Market Cap

$84.67M

224.23M

Volume · Oct 20 3.24M Avg daily vol (3M) 2.69M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-09-11	H.C. Wainwright 28th Annual Global Investment Conference	Conference
2026-08-11	Canaccord Genuity 46th Annual Growth Conference	Conference
2026-06-04	Jefferies Global Healthcare Conference	Conference
2026-06-03	Interim Data from the MyPEAK-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy	Earnings call
2026-05-15	Q1 FY2026 Earnings conference call (announced in 8-K)	Earnings call
2026-03-09	Leerink Global Healthcare Conference	Conference
2025-12-11	Interim Data from RIDGE-1 Phase 1b Clinical Trial of TN-401 in Adults with PKP2-associated ARVC	Event
2025-11-10	Interim Clinical Data from MyPEAK-1 Evaluating Safety and Early Efficacy of TN-201 in Adult Patients with MYBPC3-Associated HCM	Event
2025-10-14	H.C. Wainwright Genetic Medicines Virtual Conference	Conference
2025-09-09	Morgan Stanley 23rd Annual Global Healthcare Conference	Conference
2025-08-26	Measuring Protein Expression in Cardiac Gene Therapy - KOL Webcast Event	Event
2025-08-12	Canaccord Genuity 45th Annual Growth Conference	Conference

Source: https://investors.tenayatherapeutics.com/

Key facts CIK 1858848 CUSIP 87990A106 13F (30d) 6 filings 6 filers Visit website Investor relations